Galera Therapeutics, Inc. (GRTX) Free cash flow 2018–2024
Galera Therapeutics, Inc. (GRTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$12.1MFY2024 · since FY2018: -$22.5M → -$12.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$12.1M | +73.0% |
| FY2023 | -$44.9M | -3.4% |
| FY2022 | -$43.5M | +36.3% |
| FY2021 | -$68.2M | -13.7% |
| FY2020 | -$60.0M | -26.9% |
| FY2019 | -$47.3M | -110.1% |
| FY2018 | -$22.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice